🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effectiveness of Sequential Eustachian Tube Maneuvers in Hyperbaric Oxygen Conditions

RecruitingNAAges any - anyAllHospital Felicio Rocho
NCT06408363 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Middle ear barotrauma represents the predominant complication associated with hyperbaric oxygen therapy, manifesting symptoms ranging from otalgia to tympanic membrane perforation. Several pressurization protocols have been proposed to reduce the incidence of this trauma, but barotrauma is still the main cause of poor adherence to hyperbaric therapy. Therefore, this study aims to evaluate the effectiveness of serial tubal opening maneuvers to prevent barotrauma in patients undergoing treatment in a hyperbaric chamber.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient undergoing the first hyperbaric session. * Understanding and properly carrying out equalization maneuvers Exclusion Criteria: * Patients who did not understand the equalization maneuvers * Patients with specific contraindications to hyperbaric therapy * Patients with acute middle ear or tympanic membrane disease
💊

What it tests

  • Maneuver group
📍

Where

1 site
Hospital Felicio Rocho
Belo Horizonte, Brazil
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy